http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014011260-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_046b94174ff188b5b5d0c4605583ee11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9136549e91ac59221f028789b57cfb0f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16151
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-07007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
filingDate 2013-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06059108249dd28c96067f12cccfc47d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fbf058cd9a9cfdbb339db0c2ccc9267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c59e17d9cfdf08099446f5c98d7517a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0e196c1319208a06fd16b9d8a76af0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8f71ec9c2e5b98e834fc7900ecab926
publicationDate 2014-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014011260-A1
titleOfInvention Pol i promoter derived from vero cells and recombinant vector containing same
abstract The present invention relates to a pol I promoter derived from Vero cells and a recombinant vector containing the same. When the pol I promoter derived from Vero cells according to the present invention is utilized, viruses can be manufactured efficiently, and consequently, the manufacture of both seasonal influenza vaccine and pandemic vaccine can be prepared more quickly to usefully address either situation.
priorityDate 2011-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004029251-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012189656-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007134270-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65028
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534785
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9534
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9534

Total number of triples: 41.